Cargando…
Relative Efficacy of (225)Ac-PSMA-617 and (177)Lu-PSMA-617 in Prostate Cancer Based on Subcellular Dosimetry
OBJECTIVES: Radionuclide therapy targeting prostate-specific membrane antigen (PSMA) with alpha-emitting (225)Ac-PSMA-617 has shown clinical efficacy even in cases of failed therapy with beta-emitting (177)Lu-PSMA-617. We investigated the efficacy of (225)Ac-PSMA-617 relative to (177)Lu-PSMA-617 usi...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Galenos Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814544/ https://www.ncbi.nlm.nih.gov/pubmed/35114745 http://dx.doi.org/10.4274/mirt.galenos.2021.63308 |